Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States.
Siddharth ArunachalumKevin VeladoRobert A VigerskyToni L CorderoPublished in: Journal of diabetes science and technology (2022)
Real-world HCL system use in the U.S. demonstrated overall glycemic control that trended similarly with the system pivotal trial outcomes and previous real-world system use analyses.